Thursday, May 2, 2013

• Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior yearPR Newswire( (Thu 7:00AM EDT)
• Sanofi Q1 2013 - Interview with CFO Jérôme ContamineBusiness Wire( (Thu 1:45AM EDT)

Wednesday, May 1, 2013

• Sanofi Pasteur Scholarships awarded to four HEC Montréal studentsCNW Group( (Wed, May 1)

Tuesday, April 30, 2013

• NextBio Announces Translational Medicine Partnership with SanofiPR Newswire( (Tue, Apr 30)

Thursday, April 25, 2013

• Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC StudyBusiness Wire( (Thu, Apr 25)

Tuesday, April 23, 2013

• U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosaPR Newswire( (Tue, Apr 23)

Thursday, April 18, 2013

• Genzyme Convenes 13th European Fabry Disease RoundtableBusiness Wire( (Thu, Apr 18)

Thursday, April 11, 2013

• Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology Industry by Canadian Healthcare Marketing Hall of FameCNW Group( (Thu, Apr 11)
• New Allegra® Anti-Itch Cream Introduced by Sanofi's ChattemPR Newswire( (Thu, Apr 11)

Monday, April 8, 2013

• Genzyme’s Once-daily, Oral AUBAGIO® (teriflunomide) Approved in Argentina for the Treatment of Relapsing Multiple SclerosisBusiness Wire( (Mon, Apr 8)

Thursday, March 28, 2013

• Basketball Legend Lisa Leslie Teams Up with Allegra® to Help Families Enjoy Outdoor Workouts This Allergy SeasonPR Newswire( (Thu, Mar 28)

Monday, March 25, 2013

• Sanofi and Transgene Announce Innovative Long-Term Collaboration for the Production of Immunotherapy TreatmentsBusiness Wire( (Mon, Mar 25)